MedPath

Carbetocin

Generic Name
Carbetocin
Brand Names
Duratocin
Drug Type
Small Molecule
Chemical Formula
C45H69N11O12S
CAS Number
37025-55-1
Unique Ingredient Identifier
88TWF8015Y
Background

Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.

Indication

Used to control postpartum hemorrhage and bleeding after giving birth.

Associated Conditions
Postpartum Haemorrhage (PPH), Uterine Atony

Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

Phase 4
Not yet recruiting
Conditions
Cardiac Ischemia
Cesarian Section
Interventions
First Posted Date
2025-04-27
Last Posted Date
2025-04-27
Lead Sponsor
Jordan Leitch
Target Recruit Count
200
Registration Number
NCT06946589
Locations
🇨🇦

Kingston Health Sciences Centre, Kingston, Ontario, Canada

Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

Not Applicable
Recruiting
Conditions
Postpartum Hemorrhage (Primary)
Interventions
First Posted Date
2025-04-16
Last Posted Date
2025-04-16
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
40
Registration Number
NCT06930391
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

Completed
Conditions
PREG1
Interventions
First Posted Date
2024-11-18
Last Posted Date
2025-03-24
Lead Sponsor
Ankara City Hospital Bilkent
Target Recruit Count
120
Registration Number
NCT06692621
Locations
🇹🇷

Ankara Bilkent City Hospital, Ankara, Turkey

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Phase 3
Conditions
Hyperphagia in Prader-Willi Syndrome
Interventions
First Posted Date
2024-05-20
Last Posted Date
2025-05-04
Lead Sponsor
ACADIA Pharmaceuticals Inc.
Target Recruit Count
160
Registration Number
NCT06420297
Locations
🇩🇪

KJF Klinik Josefinum gGmbH, Augsburg, Germany

🇺🇸

Children's of Alabama, Birmingham, Alabama, United States

🇺🇸

Phoenix Children's Hospital, Phoenix, Arizona, United States

and more 22 locations

Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery

Not Applicable
Recruiting
Conditions
Post Partum Hemorrhage
Interventions
First Posted Date
2024-03-27
Last Posted Date
2025-01-22
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
160
Registration Number
NCT06333340
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

Not Applicable
Recruiting
Conditions
Postpartum Hemorrhage
Interventions
First Posted Date
2024-02-29
Last Posted Date
2025-02-26
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
32
Registration Number
NCT06285409
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women

Phase 1
Completed
Conditions
Obesity, Maternal
Post Partum Hemorrhage
Interventions
First Posted Date
2024-01-22
Last Posted Date
2024-01-22
Lead Sponsor
Cairo University
Target Recruit Count
150
Registration Number
NCT06217354
Locations
🇪🇬

Shaimaa El Shemy, Giza, Cairo, Egypt

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Phase 3
Recruiting
Conditions
Hyperphagia in Prader-Willi Syndrome
Interventions
Drug: Placebo
First Posted Date
2023-12-15
Last Posted Date
2025-04-03
Lead Sponsor
ACADIA Pharmaceuticals Inc.
Target Recruit Count
170
Registration Number
NCT06173531
Locations
🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

🇫🇷

Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse, France

🇺🇸

Children's of Alabama, Birmingham, Alabama, United States

and more 30 locations

Carbetocin in the Prevention of Primary Postpartum Haemorrhage

Completed
Conditions
Post Partum Hemorrhage
Interventions
First Posted Date
2023-12-07
Last Posted Date
2023-12-07
Lead Sponsor
Ministry of Health and Population, Egypt
Target Recruit Count
244
Registration Number
NCT06159959
Locations
🇪🇬

Kasr- Alainy Hospitals, Cairo, Egypt

Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss

Phase 1
Completed
Conditions
Uterine Fibroid
Interventions
First Posted Date
2023-08-14
Last Posted Date
2023-10-17
Lead Sponsor
Egymedicalpedia
Target Recruit Count
62
Registration Number
NCT05986266
Locations
🇪🇬

Faculty of medicine, Cairo University, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath